We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

212 hedge funds and large institutions have $2.42B invested in Select Medical in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 80 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

8% more capital invested

Capital invested by funds: $2.23B → $2.42B (+$186M)

0.33% more ownership

Funds ownership: 148.98%149.31% (+0.33%)

3% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 35

2% less funds holding

Funds holding: 216212 (-4)

13% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 80

83% less call options, than puts

Call options by funds: $785K | Put options by funds: $4.6M

Holders
212
Holders Change
-4
Holders Change %
-1.85%
% of All Funds
3.41%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
34
Increased
70
Reduced
80
Closed
35
Calls
$785K
Puts
$4.6M
Net Calls
-$3.81M
Net Calls Change
-$3.4M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$512M +$28.1M +2,172,770 +6%
BlackRock
2
BlackRock
New York
$426M +$14.6M +1,127,559 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$296M +$5.74M +443,938 +2%
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$164M +$5.54M +428,530 +4%
CCM
5
Camber Capital Management
Massachusetts
$119M
LSV Asset Management
6
LSV Asset Management
Illinois
$112M -$22.8M -1,764,889 -17%
State Street
7
State Street
Massachusetts
$104M +$3.56M +275,578 +4%
HRCM
8
Hood River Capital Management
Florida
$57M +$55.1M +4,262,755 New
Principal Financial Group
9
Principal Financial Group
Iowa
$54.4M +$1.84M +142,574 +4%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$52.3M -$637K -49,260 -1%
Invesco
11
Invesco
Georgia
$49.9M +$745K +57,642 +2%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$45.8M +$1.59M +122,839 +4%
Charles Schwab
13
Charles Schwab
California
$32.9M +$1.53M +118,569 +5%
Northern Trust
14
Northern Trust
Illinois
$30M +$362K +28,011 +1%
Victory Capital Management
15
Victory Capital Management
Texas
$26.7M -$11.9M -920,100 -32%
Morgan Stanley
16
Morgan Stanley
New York
$25.6M -$641K -49,593 -3%
Norges Bank
17
Norges Bank
Norway
$24M -$2.21M -170,865 -9%
Nuveen
18
Nuveen
North Carolina
$18.7M +$2.53M +195,836 +16%
Goldman Sachs
19
Goldman Sachs
New York
$14.1M +$5.17M +399,877 +61%
Ameriprise
20
Ameriprise
Minnesota
$11.6M +$300K +23,248 +3%
SGCIA
21
Smith Graham & Co Investment Advisors
Texas
$10.8M -$36.2K -2,801 -0.3%
RA
22
Royce & Associates
New York
$10.3M -$226K -17,446 -2%
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$7.75M +$104K +8,025 +1%
Fidelity Investments
24
Fidelity Investments
Massachusetts
$7.68M +$1.53M +118,162 +26%
Legal & General Group
25
Legal & General Group
United Kingdom
$7.62M +$118K +9,129 +2%

SEM Hedge Fund Activity: Q4 2022 in Review

212 of the 6,225 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q4 2022, worth a combined $2.42B — up 8.3% from $2.23B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of SEM and 34 opened new positions — a net loss of 1 holder — while 80 trimmed existing stakes and 70 added.

The largest buyer was Hood River Capital Management, opening a new position worth an estimated $55.1M. The largest seller was Macquarie Group, cutting an estimated $41M.

  • 212 institutional investors held Select Medical (SEM) as of Q4 2022, down from 216 in Q3 2022.
  • Funds reported $2.42B of Select Medical stock for Q4 2022, up 8.3% quarter-over-quarter.
  • 34 funds opened new Select Medical positions in Q4 2022 and 35 closed out, a net change of -1 holder.
  • The largest Select Medical buyer in Q4 2022 was Hood River Capital Management, an estimated $55.1M added.
  • The largest Select Medical seller in Q4 2022 was Macquarie Group, an estimated $41M sold.

Based on aggregated 13F filings for Q4 2022.